Product Dossier

TABRECTA

Product Dossier for TABRECTA (capmatinib, Novartis Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes, AusPAR — compiled by arcimedes.

• Sponsor: Novartis Pharmaceuticals
• Active ingredient: capmatinib
• Therapeutic area: Oncology
• Same area: TALZENNA
• Same area: ZARZIO

AusPAR (TGA)